Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

2HD6

Crystal structure of the human carbonic anhydrase II in complex with a hypoxia-activatable sulfonamide.

Summary for 2HD6
Entry DOI10.2210/pdb2hd6/pdb
Related1CA2
DescriptorCarbonic anhydrase 2, ZINC ION, CHLORIDE ION, ... (7 entities in total)
Functional Keywordsprotein-inhibitor complex, lyase
Biological sourceHomo sapiens (human)
Cellular locationCytoplasm: P00918
Total number of polymer chains1
Total formula weight29980.90
Authors
De Simone, G.,Vitale, R.M.,Di Fiore, A.,Pedone, C. (deposition date: 2006-06-20, release date: 2006-10-03, Last modification date: 2023-08-30)
Primary citationDe Simone, G.,Vitale, R.M.,Di Fiore, A.,Pedone, C.,Scozzafava, A.,Montero, J.L.,Winum, J.Y.,Supuran, C.T.
Carbonic anhydrase inhibitors: Hypoxia-activatable sulfonamides incorporating disulfide bonds that target the tumor-associated isoform IX.
J.Med.Chem., 49:5544-5551, 2006
Cited by
PubMed Abstract: An approach for designing bioreductive, hypoxia-activatable carbonic anhydrase (CA, EC 4.2.1.1) inhibitors targeting the tumor-associated isoforms is reported. Sulfonamides incorporating 3,3'-dithiodipropionamide/2,2'-dithiodibenzamido moieties were prepared and reduced enzymatically/chemically in conditions present in hypoxic tumors, leading to thiols. The X-ray crystal structure of the most promising compound, 4-(2-mercaptophenylcarboxamido)benzenesulfonamide, which as disulfide showed a K(I) against hCA IX of 653 nM (in reduced form of 9.1 nM), in adduct with hCA II showed the inhibitor making favorable interactions with Gln92, Val121, Phe131, Leu198, Thr199, Thr200, Pro201, and Pro202, whereas the sulfamoyl moiety was coordinated to the Zn2+ ion. The same interactions were preserved in the adduct with hCA IX, but in addition, a hydrogen bond between the SH moiety of the inhibitor and the amide nitrogen of Gln67 was evidenced, which may explain the almost 2 times more effective inhibition of the tumor-associated isozyme over the cytosolic isoform.
PubMed: 16942027
DOI: 10.1021/jm060531j
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.8 Å)
Structure validation

246333

数据于2025-12-17公开中

PDB statisticsPDBj update infoContact PDBjnumon